Assessment of the Knowledge and Practice on Safe Handling of Anticancer Drugs among Pharmacists in Iraqi Healthcare Settings
DOI:
https://doi.org/10.54133/ajms.v7i1.1040Keywords:
Anticancer drugs, Knowledge, Pharmacists, Safe handling practicesAbstract
Background: Occupational exposure to hazardous drugs occurs in all aspects of anticancer drug handling. Proper recommendations and guidelines should be applied to control and reduce exposure. Objective: To assess pharmacists' knowledge and practice regarding the safe handling of anticancer drugs. Methods: A cross-sectional study was conducted at seven major hospitals in Baghdad City, Iraq, from December 2023 to February 2024. A pre-designed questionnaire was given to pharmacists who handled anticancer drugs in chemotherapy units. The questionnaire comprises sociodemographic data, knowledge of the safe handling of cytotoxic drugs and thoughts about exposure and risk, practices for safely handling cytotoxic drugs, and challenges for safely handling cytotoxic drugs. Results: A total of 126 pharmacists were enrolled in the study. Less than half of the participants (46%) received training on anticancer drugs. While more than a third (42.9%) of the pharmacists were handling more than 100 cytotoxic preparations weekly, the total knowledge score was 7.14, while the total practice score was 73.36, with less than half of the pharmacists having good knowledge (44.44%) or practice (48.41%). Pharmacists who received training had significantly higher total practice scores than those who did not. Pharmacists with more than 100 weekly preparations were more knowledgeable than those with 50–99 preparations. Conclusions: The majority of participating pharmacists had fair to excellent knowledge and practice regarding the safe handling of cytotoxic medications. However, there were some gaps regarding important knowledge and practice issues. To improve knowledge and practices regarding anticancer handling, training is necessary.
Downloads
References
Power LA. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm. 1990;47(5):1033-1049. doi: 10.1093/ajhp/47.5.1033.
Centers for Disease Control and Prevention. NIOSH alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Cincinnati: National Institute for Occupational Safety and Health (Accessed 10/10/2023). 2004 Sep. Available from: https://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf.
Centers for Disease Control and Prevention. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010 (Accessed 10/10/2023). Available from: https://www.cdc.gov/niosh/docs/2010-167/pdfs/2010-167.pdf?id=10.26616/NIOSHPUB2010167.
Centers for Disease Control and Prevention. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012 (Accessed 10/10/2023). Available from: https://www.cdc.gov/niosh/docket/archive/docket190.html.
Centers for Disease Control and Prevention. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2014 (Accessed 10/10/2023). Available from: https://www.cdc.gov/niosh/docs/2014-138/pdfs/2014-138_v3.pdf?id=10.26616/NIOSHPUB2014138.
Centers for Disease Control and Prevention. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2016 (Accessed 10/10/2023). Available from: https://www.cdc.gov/niosh/docs/2016-161/pdfs/2016-161.pdf?id=10.26616/NIOSHPUB2016161.
Centers for Disease Control and Prevention. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2020 (Accessed 10/10/2023). Available from: https://www.cdc.gov/niosh/docket/review/docket233c/pdfs/DRAFT-NIOSH-Hazardous-Drugs-List-2020.pdf.
Mansour KA. Effectiveness of an educational program on nurses' knowledge regarding management of extravasation vesicant intravenous chemotherapy at oncology centers in Baghdad city. Iraqi Natl J Nurs Spec. 2019;32(2):75-86. doi: 10.58897/injns.v32i2.338.
Fadhil I, Hassan H. Evaluation of nurses’ practices toward safe intravenous chemotherapy infusion in Baghdad City hospitals. Iraqi Natl J Nurs Spec. 2018;31(2):43-56. doi: 10.58897/injns.v31i2.306.
Jacobson JO, Polovich M, Gilmore TR, Schulmeister L, Esper P, LeFebvre KB, et al. Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards: Expanding the scope to include inpatient settings. J Oncol Practice. 2012;39(1):31-38. doi: 10.1200/JOP.2011.000339.
Celano P, Fausel CA, Kennedy EB, Miller TM, Oliver TK, Page R, et al. Safe handling of hazardous drugs: ASCO standards. J Clin Oncol. 2019;37(7):598-609. doi: 10.1200/JCO.18.01616.
Nabhani-Gebara S. ISOPP Standards for the safe handling of cytotoxics. J Oncol Pharm Pract. 2022;28(3):1-126. doi: 10.1177/10781552211070933.
Alkashaf KH, Mohammed SI. Impact of Clinical Pharmacist Intervention on Chemotherapy Knowledge, Attitude, and Practice among Breast Cancer Women. J Fac Med Baghdad. 2024;66(1):103-109. doi: 10.32007/jfacmedbagdad.6612221.
Ogbaghebriel A, Alshamrani M, Ibrahim A, Al-Masaary W, Hakami S, Alrasheed S, et al. Pharmacy practitioners’ adherence to safe-handling practices of chemotherapeutic drugs: A cross-sectional study in Saudi Arabia. J Oncol Pharm Pract. 2022;0(0):1-8. doi: 10.1177/10781552221105584.
Abid JM, Mohammed WK. Effectiveness of an Instructional Program on Patientsꞌ Knowledge about Home Safety While Receiving Anti-Cancer Medications at Al-Karama Teaching Hospital in Al-Kut City. Iraqi Natl J Nurs Spec. 2021;34(2):8-15. doi: 10.58897/injns.v34i2.571.
Alaraidh S, Alnaim LS, Almazrou SH. Impact of Educational Intervention on Compliance of Health Care Workers Towards Chemotherapy Handling Guidelines. J Multidiscip Healthc. 2023;16(0):3035-3042. doi: 10.2147/JMDH.S426931.
NIOSH [2023]. Managing hazardous drug exposures: information for healthcare settings. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health (Accessed 10/10/2023). Available from: doi: 10.26616/NIOSHPUB2023130.
Liu S, Huang Y, Huang H, Hu S, Zhong X, Peng J, et al. Influence of occupational exposure to antineoplastic agents on adverse pregnancy outcomes among nurses: A meta‐analysis. Nurs Open. 2023;10(9):5827-5837. doi: 10.1002/nop2.1853.
Al-Azzam SI, Awawdeh BT, Alzoubi KH, Khader YS, Alkafajei AM. Compliance with safe handling guidelines of antineoplastic drugs in Jordanian hospitals. J Oncol Pharm Pract. 2015;21(1):3-9. doi: 10.1177/1078155213517128.
Bayraktar-Ekincioglu A, Korubük G, Demirkan K. An evaluation of chemotherapy drug preparation process in hospitals in Turkey–A pilot study. J Oncol Pharm Pract. 2018 Dec;24(8):1-10. doi: 10.1177/1078155217720007.
Yang S, Patel P, Corcoran A, Dobberpuhl E, Isidro S, Le D, et al. Gaps in Patient Education on Safe Handling and Disposal of Oral Chemotherapy Drugs: A Pilot Prospective Cohort Survey Study. J contemporary pharm pract. 2022;70(2):23-33.
Von Grünigen S, Geissbühler A, Bonnabry P. Cyto-SAT: A self-assessment tool for the safe handling of cytotoxic drugs adapted for use in low- and middle-income countries. J Oncol Pharm Pract. 2020;27(6):1422–1431. doi: 10.1177/1078155220956687.
Raya Musa Muhammad. Assessment of Knowledge and Practice for Safe Handling of Antineoplastic Drugs among Healthcare Providers in Oncology Departments in Palestinian Hospitals (Accessed 8/10/2023). Available from: https://repository.najah.edu/bitstreams/55a96973-2674-4fb1-a91f-669f771f636f/download.
Verstrate C. Exploration of Chemotherapy Safe-Handling Practices and Identification of Knowledge Deficits among Oncology Nurses in the Ambulatory Care Setting (Accessed 5/10/2023). Available from: https://scholarworks.gvsu.edu/cgi/viewcontent.cgi?article=1027&context=dissertations.
Qadir CS, Mahmood EK, Osman GA, Esmail DH, Omar YB. Safe handling knowledge and practices of chemotherapy among oncology nurses in Erbil City. kufa J Nurs scienc. 2016;6(1):19-25. doi: 10.36321/kjns.vi20161.2623.
Ness SL, Mascarenhas MÁ, Arbo MD, Tonietto BD, Cestonaro LV, Dos Santos et al. Occupational exposure assessment in professionals who manipulate and administer antineoplastic drugs in a university hospital in Southern Brazil. J Oncol Pharm Pract. 2021;27(5):1-9. doi: 10.1177/10781552211003638.
Hon CY, Teschke K, Shen H. Health care workers’ knowledge, perceptions, and behaviors regarding antineoplastic drugs: survey from British Columbia, Canada. J Occup Environ Hyg. 2015 Oct 3;12(10):669-677. doi: 10.1080/15459624.2015.1029618.
Huff C. Oral chemotherapy: a home safety educational framework for healthcare providers, patients, and caregivers. Clin J Oncol Nurs. 2020;24(1):22-30. doi: 10.1188/20.CJON.22-30.
Al-Attar WM, Al-Gannem M. Effectiveness of the nursing educational program upon nurse’s knowledge and practices concerning chemotherapy precautions. IOSR-JNHS. 2015 Nov;4(6):7-13. doi: 10.9790/1959-04630713.
Kamil AH, Mohammed SJ. Effectiveness of an Instructional Program on Knowledge of Patients Undergoing Chemotherapy toward Self-care in Baqubah Teaching Hospital. Indian J Public Health Res Development. 2020;11(02):1049. doi: 10.37506/ijphrd.v11i4.9204.
Mahmoud I, Mohammed K. Evaluation of the Nursing Intervention for Patients with Cancer Undergoing Chemotherapy in AL_Amal National Hospital for Cancer Management and Baghdad Teaching Hospital. Kufa J Nurs Scien. 2015;5(2):1-8. doi: 10.36321/kjns.vi20152.2598.
Mohammed SI, Dawood EB, Abaas IS. Perceptions and attitudes of community pharmacists towards patient counseling and continuing pharmacy education programs in Iraq. Iraqi J Pharm Sci. 2019;28(2):30-6. doi: 10.31351/vol28iss2pp30-36.
Mucci N, Dugheri S, Farioli A, Garzaro G, Rapisarda V, Campagna M, et al. Occupational exposure to antineoplastic drugs in hospital environments: potential risk associated with contact with cyclophosphamide-and ifosfamide-contaminated surfaces. Med Pr. 2020;71(5):519-529. doi: 10.13075/mp.5893.00931.
Redic KA, Fang K, Christen C, Chaffee BW. Surface contamination of hazardous drug pharmacy storage bins and pharmacy distributor shipping containers. J Oncol Pharm Pract. 2018;24(2):1-7. doi: 10.1177/1078155216679027.
Hedmer M, Georgiadi A, Bremberg ER, Jönsson BA, Eksborg S. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Ann Occup Hyg. 2005;49(7):629-637. doi: 10.1093/annhyg/mei042.
Mason HJ, Morton J, Garfitt SJ, Iqbal S, Jones K. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg. 2003;47(8):681-685. doi: 10.1093/annhyg/meg078.
Hilliquin D, Bussières JF. External contamination of antineoplastic drug containers from a Canadian wholesaler. J Oncol Pharm Pract. 2020;26(2):1-5. doi: 10.1177/1078155219868525.
Schierl R, Herwig A, Pfaller A, Groebmair S, Fischer E. Surface contamination of antineoplastic drug vials: comparison of unprotected and protected vials. Am J Health-Syst Pharm. 2010;67(6):428-429. doi: 10.2146/ajhp080621.
Naito T, Osawa T, Suzuki N, Goto T, Takada A, Nakamichi H, et al. Comparison of contamination levels on the exterior surfaces of vials containing platinum anticancer drugs in Japan. Biol Pharm Bull. 2012;35(11):2043-2049. doi:10.1248/bpb.b12-00628.
Touzin K, Bussières JF, Langlois É, Lefebvre M, Gallant C. Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination. Ann Occup Hyg. 2008;52(8):765-771. doi: 10.1093/annhyg/men050.
Power LA, Sessink PJ, Gesy K, Charbonneau F. Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process. Hosp Pharm. 2014;49(4):355-362. doi: 10.1310/hpj4904-355.
Power LA, Coyne JW. ASHP guidelines on handling hazardous drugs. Ame J Health-Syst Pharm. 2018;75(24):1996-2031. doi: 10.2146/ajhp180564.
Topçu S, Beşer A. Oncology nurses’ perspectives on safe handling precautions: A qualitative study. Contemp Nurse. 2017;53(3):271-283. doi: 10.1080/10376178.2017.1315828.
Preventing Occupational exposure to cytotoxic and other hazardous drugs. Policy recommendations. (Accessed 10/10/2023). Available from: https://www.europeanbiosafetynetwork.eu/wp-content/uploads/2016/05/Exposure-to-Cytotoxic-Drugs_Recommendation_DINA4_10-03-16.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).
